Jointown Pharmaceutical Group Co., Ltd (SHA:600998)

SHA:600998 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17,094	17,390	16,949	17,176	14,702	14,809
Short-Term Investments	-	15.11	95.01	90	289.15	103.76
Trading Asset Securities	62.36	972.34	90.03	319.72	3,597	15.31
Cash & Short-Term Investments	17,157	18,378	17,134	17,586	18,588	14,928
Cash Growth	17.89%	7.26%	-2.57%	-5.39%	24.51%	22.53%
Accounts Receivable	38,219	31,627	29,375	30,511	28,224	27,269
Other Receivables	6,761	4,094	3,159	2,395	3,029	5,245
Receivables	44,980	35,721	32,534	32,907	31,305	32,514
Inventory	22,814	22,851	20,114	17,213	15,517	14,775
Prepaid Expenses	-	17.64	16.8	-	22.94	5.22
Other Current Assets	5,198	7,257	5,826	7,952	5,737	3,927
Total Current Assets	90,148	84,225	75,625	75,658	71,170	66,150
Property, Plant & Equipment	8,741	8,978	8,963	8,648	8,521	7,413
Long-Term Investments	3,961	4,092	3,552	3,298	2,413	3,723
Goodwill	803.76	799.37	759.68	813.38	581.43	554.33
Other Intangible Assets	2,279	2,112	1,895	1,863	2,195	2,257
Long-Term Accounts Receivable	-	-	-	-	-	1.95
Long-Term Deferred Tax Assets	821.82	658.83	476.42	434.7	288.42	245.67
Long-Term Deferred Charges	245.97	224.97	283.7	261.01	196.38	122.65
Other Long-Term Assets	1,880	1,306	1,233	1,336	570.62	355.48
Total Assets	108,880	102,396	92,789	92,312	85,936	80,824
Accounts Payable	50,318	46,510	40,101	39,295	34,158	31,099
Accrued Expenses	373.29	810.71	786.92	780.82	631.62	446.55
Short-Term Debt	12,781	9,936	10,122	11,493	13,055	14,325
Current Portion of Long-Term Debt	1,418	1,389	2,040	413.42	1,767	-
Current Portion of Leases	-	170.82	78.65	79.21	87.16	-
Current Income Taxes Payable	499.53	545.81	267.28	306.73	178.7	349.96
Current Unearned Revenue	1,278	1,708	1,704	2,502	966.06	929.71
Other Current Liabilities	4,742	5,333	4,966	4,814	4,551	4,182
Total Current Liabilities	71,409	66,403	60,066	59,684	55,394	51,332
Long-Term Debt	995.15	1,018	2,336	2,980	2,379	3,205
Long-Term Leases	941.37	698.94	170.99	195.64	180.29	-
Long-Term Unearned Revenue	237.89	336.33	360.7	306.49	343.39	317.41
Long-Term Deferred Tax Liabilities	436.26	346.58	378.47	459.6	566.11	352.26
Other Long-Term Liabilities	84.17	-	-	-	-	-
Total Liabilities	74,104	68,803	63,312	63,626	58,863	55,207
Common Stock	5,042	5,042	3,909	1,874	1,874	1,874
Additional Paid-In Capital	-	5,207	6,353	8,205	8,056	8,095
Retained Earnings	16,556	15,585	14,054	12,950	11,546	10,155
Treasury Stock	-632.46	-632.46	-581.86	-774.24	-614.82	-858.06
Comprehensive Income & Other	5,492	2,041	248.37	402.59	564.73	578.67
Total Common Equity	26,458	27,243	23,983	22,657	21,426	19,844
Minority Interest	6,546	6,350	5,494	4,046	3,664	3,790
Shareholders' Equity	34,776	33,593	29,477	28,685	27,073	25,617
Total Liabilities & Equity	108,880	102,396	92,789	92,312	85,936	80,824
Total Debt	16,135	13,212	14,747	15,162	17,469	17,530
Net Cash (Debt)	1,021	5,165	2,387	2,424	1,119	-2,602
Net Cash Growth	-	116.38%	-1.52%	116.56%	-	-
Net Cash Per Share	0.20	1.03	0.47	0.46	0.22	-0.49
Filing Date Shares Outstanding	5,105	4,986	5,026	4,912	4,963	4,921
Total Common Shares Outstanding	5,105	4,986	5,026	4,945	4,963	4,921
Working Capital	18,738	17,822	15,559	15,973	15,775	14,818
Book Value Per Share	5.18	5.46	4.77	4.54	4.28	3.99
Tangible Book Value	23,375	24,332	21,328	19,981	18,649	17,032
Tangible Book Value Per Share	4.58	4.88	4.24	4.00	3.72	3.42
Buildings	-	8,454	8,235	7,515	6,536	5,589
Machinery	-	3,369	3,219	2,965	2,779	2,451
Construction In Progress	-	383.92	634.92	865.37	1,523	1,682

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.